{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T11:32:49Z","timestamp":1767699169994,"version":"3.48.0"},"reference-count":30,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81802468"],"award-info":[{"award-number":["81802468"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: Progressive familial intrahepatic cholestasis (PFIC) describes a group of genetically heterogeneous disorders. Several mutations in the ATP-Binding Cassette Subfamily B Member 4 (ABCB4) gene have been confirmed to cause reduced phosphatidylcholine levels in bile, leading to a deficiency of biliary vesicles and instability of mixed in micelles. The disease spectrum ranges from PFIC type 3 (PFIC3) to milder conditions. Herein, we present a rare case of PFIC3 in a young woman, emphasizing the importance of early detection and management. Methods: The patient was diagnosed using next-generation sequencing, with genetic testing and analysis performed by the Chengdu Hua Chuang Testing Institute. Variant pathogenicity was evaluated according to the American College of Medical Genetics and Genomics guidelines and classified into five categories: pathogenic, likely pathogenic, uncertain significance, likely benign, and benign. Nomenclature was assigned following the Human Genome Variation Society standards. Results: Contrast-enhanced abdominal computed tomography demonstrated liver cirrhosis with marked splenomegaly. Histological examination of liver biopsy specimens using hematoxylin and eosin and Masson staining further confirmed cirrhotic changes. Genetic testing was subsequently performed and revealed a likely pathogenic variant, c.2757T &gt; A (p. Tyr919Ter), in exon 22 of the ABCB4 gene, which was also detected in the patient\u2019s mother but absent in her father. Finally, PFIC3 was diagnosed. Following initiation of ursodeoxycholic acid therapy, the patient showed moderate improvement in liver function tests, underscoring a clinical case with therapeutic implications. Conclusions: Molecular genetic analyses of ABCB4 are essential for the accurate diagnosis of PFIC3. Clinicians should consider cholestatic liver diseases, particularly PFIC, as a differential diagnosis in cases of liver cirrhosis with unknown etiology, especially in young patients who lack prior symptoms or a family history of liver disease.<\/jats:p>","DOI":"10.3390\/jcm15020412","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T11:13:18Z","timestamp":1767697998000},"page":"412","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A Rare Nonsense Mutation in the ABCB4 Gene Associated with Progressive Familial Intrahepatic Cholestasis Type 3: A Case Report"],"prefix":"10.3390","volume":"15","author":[{"given":"Binru","family":"Cai","sequence":"first","affiliation":[{"name":"Center of Infectious Diseases, West China Hospital of Sichuan University, Chengdu 610041, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1190-6667","authenticated-orcid":false,"given":"Duoduo","family":"Lv","sequence":"additional","affiliation":[{"name":"Center of Infectious Diseases, West China Hospital of Sichuan University, Chengdu 610041, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuefeng","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, West China Hospital, Sichuan University, Guoxue Lane, Chengdu 610041, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6756-6725","authenticated-orcid":false,"given":"Lingyun","family":"Zhou","sequence":"additional","affiliation":[{"name":"Center of Infectious Diseases, West China Hospital of Sichuan University, Chengdu 610041, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,1,6]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/S2468-1253(22)00093-0","article-title":"Odevixibat treatment in progressive familial intrahepatic cholestasis: A randomised, placebo-controlled, phase 3 trial","volume":"7","author":"Thompson","year":"2022","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.cld.2022.03.003","article-title":"Overview of Progressive Familial Intrahepatic Cholestasis","volume":"26","author":"Hassan","year":"2022","journal-title":"Clin. Liver Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1002\/hep.510230435","article-title":"Defect of multidrug-resistance 3 gene expression in a subtype of progressive familial intrahepatic cholestasis","volume":"23","author":"Deleuze","year":"1996","journal-title":"Hepatology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1186\/s13023-022-02597-y","article-title":"Clinical and genetic characterization of pediatric patients with progressive familial intrahepatic cholestasis type 3 (PFIC3): Identification of 14 novel ABCB4 variants and review of the literatures","volume":"17","author":"Chen","year":"2022","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/0092-8674(93)90380-9","article-title":"Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease","volume":"75","author":"Smit","year":"1993","journal-title":"Cell"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1053\/j.gastro.2005.08.052","article-title":"Hepatocanalicular transport defects: Pathophysiologic mechanisms of rare diseases","volume":"130","author":"Paulusma","year":"2006","journal-title":"Gastroenterology"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Almes, M., Spraul, A., Ruiz, M., Girard, M., Roquelaure, B., Laborde, N., Gottrand, F., Turquet, A., Lamireau, T., and Dabadie, A. (2022). Targeted-Capture Next-Generation Sequencing in Diagnosis Approach of Pediatric Cholestasis. Diagnostics, 12.","DOI":"10.3390\/diagnostics12051169"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.jhep.2025.06.010","article-title":"The history and future of bile acid therapies","volume":"83","author":"Beuers","year":"2025","journal-title":"J. Hepatol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"100949","DOI":"10.1016\/j.jhepr.2023.100949","article-title":"Opinion paper on the diagnosis and treatment of progressive familial intrahepatic cholestasis","volume":"6","author":"McKiernan","year":"2024","journal-title":"JHEP Rep."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/s41594-019-0354-3","article-title":"Structure of the human lipid exporter ABCB4 in a lipid environment","volume":"27","author":"Olsen","year":"2020","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1002\/hep.28300","article-title":"A functional classification of ABCB4 variations causing progressive familial intrahepatic cholestasis type 3","volume":"63","author":"Delaunay","year":"2016","journal-title":"Hepatology"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/s41580-023-00633-8","article-title":"Mechanisms of substrate processing during ER-associated protein degradation","volume":"24","author":"Christianson","year":"2023","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/liv.12910","article-title":"Heterozygous ABCB4 mutations in children with cholestatic liver disease","volume":"36","author":"Hierro","year":"2016","journal-title":"Liver Int."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1002\/hep.26894","article-title":"Peroxisome proliferator-activated receptor \u03b1 activates human multidrug resistance transporter 3\/ATP-binding cassette protein subfamily B4 transcription and increases rat biliary phosphatidylcholine secretion","volume":"59","author":"Ghonem","year":"2014","journal-title":"Hepatology"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/MPG.0b013e3181f50363","article-title":"Clinical features and genotype-phenotype correlations in children with progressive familial intrahepatic cholestasis type 3 related to ABCB4 mutations","volume":"52","author":"Colombo","year":"2011","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S1665-2681(19)30771-9","article-title":"Reversal of advanced fibrosis after long-term ursodeoxycholic acid therapy in a patient with residual expression of MDR3","volume":"14","author":"Frider","year":"2015","journal-title":"Ann. Hepatol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1136\/gutjnl-2014-306896","article-title":"Functional analysis of ABCB4 mutations relates clinical outcomes of progressive familial intrahepatic cholestasis type 3 to the degree of MDR3 floppase activity","volume":"64","author":"Andueza","year":"2015","journal-title":"Gut"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"100844","DOI":"10.1016\/j.jhepr.2023.100844","article-title":"Outcomes of 38 patients with PFIC3: Impact of genotype and of response to ursodeoxycholic acid therapy","volume":"5","author":"Gonzales","year":"2023","journal-title":"JHEP Rep."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jhep.2012.02.014","article-title":"Effect of ursodeoxycholic acid on bile acid profiles and intestinal detoxification machinery in primary biliary cirrhosis and health","volume":"57","author":"Dilger","year":"2012","journal-title":"J. Hepatol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1007\/s40265-016-0616-x","article-title":"Obeticholic Acid: First Global Approval","volume":"76","author":"Markham","year":"2016","journal-title":"Drugs"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/hep.32101","article-title":"Pharmacologic activation of hepatic farnesoid X receptor prevents parenteral nutrition-associated cholestasis in mice","volume":"75","author":"Ghosh","year":"2022","journal-title":"Hepatology"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1007\/s40265-021-01594-y","article-title":"Odevixibat: First Approval","volume":"81","author":"Deeks","year":"2021","journal-title":"Drugs"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S2468-1253(24)00080-3","article-title":"Maralixibat in progressive familial intrahepatic cholestasis (MARCH-PFIC): A multicentre, randomised, double-blind, placebo-controlled, phase 3 trial","volume":"9","author":"Miethke","year":"2024","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s40265-021-01649-0","article-title":"Maralixibat: First Approval","volume":"82","author":"Shirley","year":"2022","journal-title":"Drugs"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/hep.24691","article-title":"A biliary HCO3\u2212 umbrella constitutes a protective mechanism against bile acid-induced injury in human cholangiocytes","volume":"55","author":"Hohenester","year":"2012","journal-title":"Hepatology"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/j.jhep.2020.12.010","article-title":"Synthetic human ABCB4 mRNA therapy rescues severe liver disease phenotype in a BALB\/c.Abcb4\u2212\/\u2212 mouse model of PFIC3","volume":"74","author":"Wei","year":"2021","journal-title":"J. Hepatol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"100713","DOI":"10.1016\/j.jhepr.2023.100713","article-title":"Rescue of infant progressive familial intrahepatic cholestasis type 3 mice by repeated dosing of AAV gene therapy","volume":"5","author":"Weber","year":"2023","journal-title":"JHEP Rep."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1111\/j.1399-0012.2010.01368.x","article-title":"Progressive familial intrahepatic cholestasis: A single-center experience of living-donor liver transplantation during two decades in Japan","volume":"25","author":"Hori","year":"2011","journal-title":"Clin. Transpl."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s13023-025-03670-y","article-title":"Clinical and molecular genetic characteristics of pediatric PFIC3 patients: Three novel variants and prognosis for parental liver transplantation","volume":"20","author":"Hu","year":"2025","journal-title":"Orphanet J. Rare Dis."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/2\/412\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T11:26:11Z","timestamp":1767698771000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/2\/412"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,6]]},"references-count":30,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["jcm15020412"],"URL":"https:\/\/doi.org\/10.3390\/jcm15020412","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,6]]}}}